02 Apr. 2015
WILMINGTON, N.C., (April 2, 2015) – Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Jon Denissen, Ph.D., as vice president of good manufacturing practices (GMP) laboratories. Denissen brings over 25 years of experience in the pharmaceutical and contract research organization (CRO) industries. He is based in PPD’s GMP lab facility in Middleton, Wisconsin.
“Jon’s experience includes successfully leading scientific teams and building effective client relationships that facilitate research collaboration,” said David Johnston, Ph.D., executive vice president of global laboratory services for PPD. “Our GMP laboratories provide fully integrated laboratory services for all phases of drug development, and Jon’s leadership will help drive PPD’s client-centric, quality-focused culture.”
PPD’s GMP laboratories, located in Middleton, Wisconsin, and Athlone, Ireland, conduct testing for clinical programs and marketed programs spanning all phases of drug development, and support PPD’s global laboratory operations. GMP laboratories play a key role in the company’s capabilities, which include exceptional scientific expertise, broad therapeutic experience and state-of-the-art facilities and instrumentation, which combine to deliver best-in-class laboratory services.
Prior to joining PPD, Denissen held senior leadership positions within the CRO industry and several positions of increasing responsibility at Abbott Laboratories, supporting drug discovery and development programs.
He earned his bachelor’s degree in chemistry from the University of Wisconsin-Madison and completed his doctorate in organic chemistry at the University of Illinois.
PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 13,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.
+1 910 558 6096
+1 910 558 6783